Company / Current Liabilities per Share
Niagen Bioscience, Inc. Current Liabilities per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$0.26
FY2025
5-year range
$0.24 / $0.28
FY2021-FY2025
Trend
+7.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Liabilities per Share has fluctuated over the past 10 years, ranging from $0.22 in FY2017 to $273.43 in FY2019.
Based on SEC 10-K filings.
0.26 in FY2025 with a 5-year CAGR of -1.4%.
Improved from $0.28 to $0.26 over the past 2 years.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- -0.6%
- 5-Year CAGR
- -1.4%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, current liabilities per share increased 7.6% year-over-year.
- Peak current liabilities per share was recorded in FY2019.
- Lowest current liabilities per share in the period was in FY2017.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.26 | +7.6% |
| FY2024 | $0.24 | -13.4% |
| FY2023 | $0.28 | +5.4% |
| FY2022 | $0.26 | -7.8% |
| FY2021 | $0.28 | +2.9% |
| FY2020 | $0.28 | -99.9% |
| FY2019 | $273.43 | +103472.1% |
| FY2018 | $0.26 | +22.5% |
| FY2017 | $0.22 | -12.6% |
| FY2016 | $0.25 | +170.5% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026